In T2D-NAFLD patients, plasma glucagon levels were significantly higher than in individuals without NAFLD, with a positive correlation between plasma glucagon concentrations and liver fat content. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.